Bristi Basu

Medical Oncologist

Research Group Home Page: 
Jodrell Group

Work address: 
Publications: 

Quantifying normal human brain metabolism using hyperpolarized [1-13C]pyruvate and magnetic resonance imaging.

E-pub date: 31 Dec 2018

Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high grade serous ovarian and squamous non-small cell lung cancer.

E-pub date: 30 Jun 2018

Hyperpolarized carbon-13 magnetic resonance spectroscopic imaging: a clinical tool for studying tumour metabolism.

E-pub date: 31 May 2018

A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma.

E-pub date: 20 Mar 2018

Drug development and clinical trial design in pancreatico-biliary malignancies.

E-pub date: 01 Jan 2018

Early Phase Clinical Trial Designs – State of Play and Adapting for the Future.

E-pub date: 31 Dec 2017

Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study.

E-pub date: 31 Dec 2016

Intensive cisplatin/oral etoposide for epithelial ovarian cancer: the Cambridge Gynae-Oncology Centre experience: too toxic for relapse?

E-pub date: 31 Mar 2016

Safety and Efficacy of Modified FOLFIRINOX for Advanced Pancreatic Adenocarcinoma: A UK Single-Centre Experience.

E-pub date: 31 Aug 2015

First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual m-TORC 1/2 Inhibitor AZD2014.

E-pub date: 01 Aug 2015

Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study.

E-pub date: 31 Jul 2015

Progress in pancreatic cancer: moving beyond gemcitabine?

E-pub date: 31 Aug 2012

Targeting the DNA damage response in oncology: past, present and future perspectives.

E-pub date: 31 May 2012

Inhibition of MT1-MMP activity using functional antibody fragments selected against its hemopexin domain.

E-pub date: 01 Feb 2012

Targeting angiogenesis in melanoma: prospects for the future.

E-pub date: 01 Nov 2010

A phase 2 study of vatalanib in metastatic melanoma patients.

E-pub date: 31 Oct 2010

Perspectives in drug development for metastatic renal cell cancer.

E-pub date: 01 Jun 2010

Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin.

E-pub date: 31 Mar 2010

Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.

E-pub date: 01 Nov 2009

Development of a Prognostic Model That Predicts Survival After Pancreaticoduodenectomy for Ampullary Cancer.

E-pub date: 01 Jan 1970

Show all

CRUK CI staff links

Contact CRUK CI

Cancer Research UK Cambridge Institute
University of Cambridge
Li Ka Shing Centre, Robinson Way
Cambridge, CB2 0RE
Tel: +44 (0)1223 769500

Useful links

Study at Cambridge

About the University

Research at Cambridge

This Site Uses Cookies

We may use cookies to record some preference settings and to analyse how you use our web site. We may also use external analysis systems which may set additional cookies to perform their analysis.These cookies (and any others in use) are detailed in our site privacy and cookie policies and are integral to our web site. You can delete or disable these cookies in your web browser if you wish but then our site may not work correctly.